Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. A novel neurodegenerative spectrum disorder in patients with MLKL deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cytoplasmic mRNPs revisited: Singletons and condensates

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Elevated miR-9 in Cerebrospinal Fluid Is Associated with Poor Functional Outcome After Subarachnoid Hemorrhage

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Aberrant oncogene activation induces cellular senescence, an irreversible growth arrest that acts as a barrier against tumorigenesis. To identify microRNAs (miRNAs) involved in oncogene-induced senescence, we examined the expression of miRNAs in primary human TIG3 fibroblasts after constitutive activation of B-RAF. Among the regulated miRNAs, both miR-34a and miR-146a were strongly induced during senescence. Although members of the miR-34 family are known to be transcriptionally regulated by p53, we find that miR-34a is regulated independently of p53 during oncogene-induced senescence. Instead, upregulation of miR-34a is mediated by the ETS family transcription factor, ELK1. During senescence, miR-34a targets the important proto-oncogene MYC and our data suggest that miR-34a thereby coordinately controls a set of cell cycle regulators. Hence, in addition to its integration in the p53 pathway, we show that alternative cancer-related pathways regulate miR-34a, emphasising its significance as a tumour suppressor.
Original languageEnglish
JournalCell Death and Differentiation
Volume17
Issue number2
Pages (from-to)236-45
Number of pages10
ISSN1350-9047
DOIs
Publication statusPublished - 1 Feb 2010

ID: 31046382